CS logo
small CS logo
Buffalo Neuroimaging Analysis Center

Buffalo, New York, United States
Research institute in Buffalo, New York
Buffalo General Hospital D Building, 100 High Street, Buffalo, NY 14203

About Buffalo Neuroimaging Analysis Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Buffalo Neuroimaging Analysis Center


During the past decade, Buffalo Neuroimaging Analysis Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Buffalo Neuroimaging Analysis Center" #1 collaborator was "Teva Pharmaceuticals USA" with 2 trials as a collaborator, "Charles University, Czech Republic" with 1 trials as a collaborator, "General University Hospital, Prague" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Buffalo Neuroimaging Analysis Center


According to Clinical.Site data, the most researched conditions in "Buffalo Neuroimaging Analysis Center" are "Multiple Sclerosis" (7 trials), "Healthy" (1 trials), "Multiple Sclerosis, Relapsing-remitting" (1 trials), "Tecfidera" (1 trials) and "Teriflunomide" (1 trials). Many other conditions were trialed in "Buffalo Neuroimaging Analysis Center" in a lesser frequency.

Clinical Trials Intervention Types at Buffalo Neuroimaging Analysis Center


Most popular intervention types in "Buffalo Neuroimaging Analysis Center" are "Other" (3 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "MRI" (3 trials), "Dimethyl Fumarate" (1 trials), "Natalizumab discontinuation" (1 trials) and "Teriflunomide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Buffalo Neuroimaging Analysis Center


The vast majority of trials in "Buffalo Neuroimaging Analysis Center" are 9 trials for "All" genders.

Clinical Trials Status at Buffalo Neuroimaging Analysis Center


Currently, there are NaN active trials in "Buffalo Neuroimaging Analysis Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Buffalo Neuroimaging Analysis Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Buffalo Neuroimaging Analysis Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".